Detalles de la búsqueda
1.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Gynecol Oncol
; 174: 213-223, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37229879
2.
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Gynecol Oncol
; 173: 130-137, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148580
3.
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Gynecol Oncol
; 154(1): 13-21, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31053405
4.
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 151(1): 18-23, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30135020
5.
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.
Gynecol Oncol
; 148(1): 49-55, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174555
6.
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 147(2): 396-401, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935272
7.
Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23].
Gynecol Oncol
; 152(1): 220, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30360899
8.
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.
Cancers (Basel)
; 14(17)2022 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077609
9.
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
Obstet Gynecol
; 133(2): 245-254, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633128
10.
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study.
Clin Cancer Res
; 11(15): 5539-48, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16061871
11.
Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Am J Clin Oncol
; 25(6): 557-60, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12477997
12.
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
J Clin Oncol
; 26(20): 3418-25, 2008 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18612157
13.
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
J Clin Oncol
; 25(28): 4466-71, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17906207
14.
Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
Gynecol Oncol
; 100(2): 349-54, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16213007
15.
Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 88(3): 277-81, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12648575
16.
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Gynecol Oncol
; 92(2): 639-43, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14766259
17.
Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 92(1): 4-9, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14751130
Resultados
1 -
17
de 17
1
Próxima >
>>